North Brunswick, NJ — Neoventech LLC is honored to receive the Maternal and Infant Health R&D Seed Grant from the New Jersey Commission on Science, Innovation and Technology (CSIT). Awarded under Round 2 of this vital program, the grant supports our commitment to the Nurture NJ initiative. We are leveraging our expertise in drug delivery to develop innovative therapeutics that improve health outcomes for mothers and infants across the state. “This funding accelerates our mission to provide safer, more effective solutions for prenatal and postpartum care,” said Jeff Wu, Ph.D, Founder. We thank the NJ CSIT and First Lady Tammy Murphy for their leadership in maternal health innovation.

Full Announcement: NJEDA Press Release